Cubist Systematic Strategies LLC Invests $37,000 in GoHealth, Inc. (NASDAQ:GOCO)

Cubist Systematic Strategies LLC acquired a new position in shares of GoHealth, Inc. (NASDAQ:GOCO) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,747 shares of the company’s stock, valued at approximately $37,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in GOCO. Citadel Advisors LLC bought a new position in shares of GoHealth during the 4th quarter worth about $664,000. Ancora Advisors LLC bought a new position in GoHealth in the 4th quarter valued at about $408,000. Russell Investments Group Ltd. lifted its position in GoHealth by 41,225.5% in the 4th quarter. Russell Investments Group Ltd. now owns 21,076 shares of the company’s stock valued at $282,000 after acquiring an additional 21,025 shares in the last quarter. JPMorgan Chase & Co. lifted its position in GoHealth by 103.8% in the 4th quarter. JPMorgan Chase & Co. now owns 17,195 shares of the company’s stock valued at $230,000 after acquiring an additional 8,758 shares in the last quarter. Finally, Northern Trust Corp lifted its position in GoHealth by 11.6% in the 4th quarter. Northern Trust Corp now owns 48,427 shares of the company’s stock valued at $648,000 after acquiring an additional 5,040 shares in the last quarter. Institutional investors own 24.21% of the company’s stock.

GoHealth Price Performance

GoHealth stock opened at $6.49 on Tuesday. GoHealth, Inc. has a 52 week low of $6.13 and a 52 week high of $21.00. The company’s 50 day moving average price is $10.57 and its two-hundred day moving average price is $12.89. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72. The stock has a market cap of $149.33 million, a P/E ratio of -1.85 and a beta of 1.71.

GoHealth (NASDAQ:GOCO) last posted its earnings results on Tuesday, May 13th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.21). GoHealth had a negative return on equity of 17.17% and a negative net margin of 4.32%. The firm had revenue of $220.97 million for the quarter, compared to the consensus estimate of $225.91 million. On average, equities analysts predict that GoHealth, Inc. will post -5.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $18.00 price target on shares of GoHealth in a research report on Monday.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.